Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (401-410 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Ejhaem|February 26, 2024
The potential of 3rd-generation nanopore sequencing for B-cell clonotyping in lymphoproliferative disordersMarcus H Hansen, Oriane Cédile, Niels Abildgaard, et al.
Ejhaem|February 26, 2024
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patientsNaveen Pemmaraju, Branko Cuglievan, Joseph Lasky, et al.
Ejhaem|February 26, 2024
Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potentialJihee Han, Ruifang Li-Gao, Renée de Mutsert, et al.
Ejhaem|October 17, 2024
Targeted management of coexistent severe thrombophilias-A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiencyJulien Dereme, Matthew Goodyer, David Baud, et al.
Ejhaem|October 17, 2024
Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case seriesNini Aung, Margaret Bowers, Gillian Brearton, et al.
Ejhaem|October 17, 2024
Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignanciesAnoop K Enjeti, Natasha Walker, Oliver Fahey, et al.
Ejhaem|October 17, 2024
Beyond myeloid neoplasms germline guidelines: Validation of the thresholds criteria in the search of germline predisposition variantsJulia Mestre, Lorea Chaparro, Ana Manzanares, et al.
Ejhaem|October 17, 2024
<i>TP53</i> variants underlying pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remissionAlbert Itov, Karina Ilyasova, Olga Soldatkina, et al.
Ejhaem|October 17, 2024
The genomic landscape of transformed splenic diffuse red pulp small B-cell lymphomaMarta Grau, Melina Pol, Anna Montaner, et al.
Pageof 93

Showing results (401-410 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Ejhaem|February 26, 2024
The potential of 3rd-generation nanopore sequencing for B-cell clonotyping in lymphoproliferative disordersMarcus H Hansen, Oriane Cédile, Niels Abildgaard, et al.
Ejhaem|February 26, 2024
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patientsNaveen Pemmaraju, Branko Cuglievan, Joseph Lasky, et al.
Ejhaem|February 26, 2024
Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potentialJihee Han, Ruifang Li-Gao, Renée de Mutsert, et al.
Ejhaem|October 17, 2024
Targeted management of coexistent severe thrombophilias-A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiencyJulien Dereme, Matthew Goodyer, David Baud, et al.
Ejhaem|October 17, 2024
Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case seriesNini Aung, Margaret Bowers, Gillian Brearton, et al.
Ejhaem|October 17, 2024
Certainty in uncertainty: Determining the rate and reasons for reclassification of variants of uncertain significance in haematological malignanciesAnoop K Enjeti, Natasha Walker, Oliver Fahey, et al.
Ejhaem|October 17, 2024
Beyond myeloid neoplasms germline guidelines: Validation of the thresholds criteria in the search of germline predisposition variantsJulia Mestre, Lorea Chaparro, Ana Manzanares, et al.
Ejhaem|October 17, 2024
<i>TP53</i> variants underlying pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remissionAlbert Itov, Karina Ilyasova, Olga Soldatkina, et al.
Ejhaem|October 17, 2024
The genomic landscape of transformed splenic diffuse red pulp small B-cell lymphomaMarta Grau, Melina Pol, Anna Montaner, et al.
Pageof 93